Page last updated: 2024-08-25

brusatol and Neoplasms

brusatol has been researched along with Neoplasms in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's4 (100.00)2.80

Authors

AuthorsStudies
Kinghorn, AD; Ren, Y1
He, T; Li, Z; Mi, L; Su, A; Wu, W; Xing, Z; Zhang, Y; Zhou, F1
Kang, JS; Keum, YS; Nam, LB; Yoo, OK1
Guo, R; Ren, F; Tian, Z; Yang, Y1

Reviews

2 review(s) available for brusatol and Neoplasms

ArticleYear
Brusatol: A potential sensitizing agent for cancer therapy from Brucea javanica.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2023, Volume: 158

    Topics: Antineoplastic Agents; Brucea javanica; Humans; Neoplasms; Quassins; Seeds

2023
Molecular mechanisms and systemic targeting of NRF2 dysregulation in cancer.
    Biochemical pharmacology, 2020, Volume: 177

    Topics: Animals; Antineoplastic Agents; Gene Expression Regulation, Neoplastic; Humans; Kelch-Like ECH-Associated Protein 1; Lung Neoplasms; Molecular Targeted Therapy; Mutation; Neoplasms; NF-E2-Related Factor 2; Quassins; Tretinoin

2020

Other Studies

2 other study(ies) available for brusatol and Neoplasms

ArticleYear
Development of Potential Antitumor Agents from the Scaffolds of Plant-Derived Terpenoid Lactones.
    Journal of medicinal chemistry, 2020, 12-24, Volume: 63, Issue:24

    Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Biological Products; Diterpenes; Humans; Neoplasms; Sesquiterpenes; Structure-Activity Relationship; Triterpenes

2020
Nrf2 Inhibitor, Brusatol in Combination with Trastuzumab Exerts Synergistic Antitumor Activity in HER2-Positive Cancers by Inhibiting Nrf2/HO-1 and HER2-AKT/ERK1/2 Pathways.
    Oxidative medicine and cellular longevity, 2020, Volume: 2020

    Topics: Animals; Antineoplastic Agents, Immunological; Brucea; Drug Synergism; Female; Humans; Mice; Mice, Nude; Neoplasms; NF-E2-Related Factor 2; Proto-Oncogene Proteins c-akt; Quassins; Transfection; Trastuzumab

2020